Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
277studies shown
Showing 1-12 of 277
Behavioral study icon
RecruitingNCT05965622

(Cost)-Effectiveness of ABFT for Suicidal Youth.

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
SuicidalityBehavioralFrom 18 Years to 25 Years
Countries
Belgium, Netherlands
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Condition
Suicidality
Drug study icon
RecruitingNCT07219953

Brenipatide in people with Addiction

The registry lists this study as recruiting. Study locations are listed in the United States, in the United Kingdom, in Belgium, ...

In Belgium
AddictionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
Addiction
Drug study icon
RecruitingNCT07219966

Brenipatide in people with Moderate-to-Severe Addiction

The registry lists this study as recruiting. Study locations are listed in the United States, in the United Kingdom, in Belgium, ...

Location not clearly listed
AddictionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
Addiction
Drug study icon
RecruitingNCT06126224

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ...

Location not clearly listed
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06585787

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Belgium, ...

Location not clearly listed
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, Belgium, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Device study icon
RecruitingNCT07115628

Accelerated TMS for Treatment-Resistant ECT

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
Countries
Belgium
Sponsor
Universitair Ziekenhuis Brussel
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.